search
Back to results

The Cardiovascular Effects of Electronic Hookah Vaping

Primary Purpose

Endothelial Dysfunction, Inflammation, Oxidative Stress

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Traditional hookah smoking
Electronic hookah vaping
Sponsored by
University of California, Los Angeles
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Endothelial Dysfunction

Eligibility Criteria

21 Years - 39 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 21-39 years old hookah smokers: smoked hookah >12x in last 12 months
  • no history of illicit drugs or marijuana
  • no evidence of cardiopulmonary disease by history/ physical
  • no diabetes: fasting blood glucose <100 mg/dl
  • BP<140/90mmHg
  • resting HR<100 bpm
  • BMI<30kg•m2
  • no prescription medication

Exclusion Criteria:

  • exhaled CO>10 ppm (smoking non-abstinence)
  • positive pregnancy test
  • psychiatric illness

Sites / Locations

  • University of California, Los Angeles

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Traditional Charcoal-Heated Hookah followed by Electronic Hookah

Electronic followed by Traditional Charcoal-Heated Hookah

Arm Description

Participants were invited to smoke a 30-minute traditional charcoal-heated hookah-smoking session, followed by a 30-minute electronic hookah vaping session. To mitigate the impact of carryover effects, the two sessions were separated by a minimum of 7-days.

Participants were invited to vape a 30-minute electronic hookah session, followed by a 30-minute traditional charcoal-heated hookah smoking session. To mitigate the impact of carryover effects, the two sessions were separated by a minimum of 7-days.

Outcomes

Primary Outcome Measures

Flow-Mediated Dilation (FMD)
Using ultrasound, FMD of the brachial artery induced by reactive hyperemia, was used to measure endothelium-dependent vasodilator function. Baseline diameter and velocity were recorded for 45 seconds and resumed 30 seconds before cuff deflation and continuously for 2 minutes after deflation to obtain true peak vasodilatory response.
Carotid-Femoral Pulse Wave Velocity (Cf-PWV)
Using applanation tonometry, cf-PWV was used to measure central arterial stiffness.
HDL Oxidant Index (HOI)
Capacity was determined as the ability of HDL to inhibit LDL-induced oxidation of dihydrodichlorofluorescein into the fluorescent dichlorofluorescein. Capacity was expressed as an HDL oxidative index, determined by the ratio of dichlorofluorescein fluorescence in the presence and absence of HDL. An index of < 1.0 denotes protective antioxidant HDL, whereas an index of > 1.0 indicates pro-oxidant HDL.
Paraoxonase-1 (PON-1) Activity
PON-1 activity was determined by the ability of PON-1, associated with HDL, to hydrolyze paraoxon substrate. The hydrolysis of paraoxon (diethyl-p-nitrophenyl phosphate) to p-nitrophenol by PON-1 was determined by incubating 5 mL of plasma with 1.0 mM paraoxon in 100 mM tris-HCl buffer (pH, 8.5). Unit of Measure: expressed as micromoles of p-nitrophenol formed per minute for every 1 mL plasma.
Arylesterase Activity
Arylesterase activity (lipid peroxidation biomarker) was determined by the rate of hydrolysis of phenyl acetate to phenol. Briefly, 4 mL plasma was incubated with 3.5 mM phenyl acetate in 9 mM Tris-HCl buffer (pH, 8.0) containing 0.9 mM CaCl2 at RT. The kinetics of phenol formation were determined by recording the absorbance at 270 nm every 15 s for 2 min. Unit of Measure: nanomoles of product formed per minute per milliliter of plasma.
High-sensitivity C-reactive Protein (Hs-CRP) Levels
Plasma hs-CRP (inflammatory biomarker)
Tumor Necrosis Factor-α (TNFα) Concentrations
Plasma TNFα (inflammatory biomarker)

Secondary Outcome Measures

Flow-Mediated Dilation (FMD)
Using ultrasound, FMD of the brachial artery, induced by reactive hyperemia, was used to measure endothelium-dependent vasodilator function after intravenous infusion of antioxidant ascorbic acid. Infusion of antioxidant ascorbic acid was done before the e-hookah vaping session.
Endothelium-independent Vasodilator Function (Control Test for Endothelium-dependent Vasodilator Function)
As a control test for the assessment of endothelium-dependent vasodilator function, using ultrasound the brachial artery, endothelium-independent dilatation was assessed by administering sublingual nitroglycerin. This measure was assessed 10 minutes after FMD testing. Ultrasound images were recorded continuously for a total of 10 minutes
Augmentation Index (AI)
AI was used to measure central stiffness. It was calculated as the ratio of augmentation pressure (difference between the second and first systolic peaks of the aortic pressure waveform) and pulse pressure expressed as a percentage.
Interleukin 6 (IL-6) Levels
Plasma IL-6 (inflammatory biomarker).
Interleukin 10 (IL-10) Levels
Serum IL-10 (anti-inflammatory biomarker)
Nicotine Levels
Plasma nicotine levels (smoking or vaping exposure biomarker)
Carbon Monoxide (CO) Levels
Exhaled CO levels (smoking or vaping exposure biomarker)

Full Information

First Posted
September 26, 2018
Last Updated
July 24, 2023
Sponsor
University of California, Los Angeles
Collaborators
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT03690427
Brief Title
The Cardiovascular Effects of Electronic Hookah Vaping
Official Title
Investigating the Cardiovascular Toxicity of Exposure to Electronic Hookah Smoking
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
December 11, 2018 (Actual)
Primary Completion Date
August 31, 2021 (Actual)
Study Completion Date
September 27, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles
Collaborators
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Hookah (water-pipe) tobacco smoking has quickly grown to become a major global tobacco epidemic among youth; with electronic (e-) hookahs more recently increasing in popularity especially among young female adults, who endorse marketing claims that these products are a safer alternative to traditional hookah, but scientific evidence is lacking. The study aims to elucidate the comparative effects of traditional hookah smoking vs. e-hookah vaping on human vascular and endothelial function; and examine the role of inflammation and oxidative stress, as likely mechanisms in hookah-related cardiovascular disease pathogenesis.
Detailed Description
Hookah (water-pipe) tobacco smoking is rapidly increasing in popularity worldwide. Contributing to this popularity is the unsubstantiated belief that traditional charcoal-heated hookah smoke is detoxified as it passes through the water-filled basin. More recently, electronic (e-) hookahs-containing flavored e-liquid that is heated electrically but inhaled through traditional water-pipes-are increasing in popularity in the United States among young female adults, who endorse marketing claims that these products are even safer than traditional charcoal-heated hookah products. The objective of this project is to investigate the comparative effects of traditional charcoal-heated hookah smoking versus e-hookah vaping on endothelial and vascular function and their mechanistic role in the development of cardiovascular disease. The investigators will test the hypothesis that: 1) in the absence of burning charcoal briquettes and virtually any carbon monoxide (CO) exposure, e-hookah vaping acutely impairs endothelial function and evokes acute central arterial stiffness, opposite from the endothelial function augmentation observed after traditional charcoal-heated hookah smoking, which is likely mediated by the large CO boost emitted from burning charcoal briquettes used to heat the flavored hookah tobacco; and 2) the processes of oxidative stress and inflammation play a pivotal mechanistic role underlying these vascular changes. Accordingly, in a cross-over study comparing traditional hookah smoking to e-hookah vaping, the investigators will assess endothelial function measured by brachial artery flow-mediated dilation and aortic stiffness by pulse wave velocity and augmentation index in 18 young healthy hookah smokers 21-39 years old, before and after ad lib 30-minute smoking/ vaping exposure sessions. To test for oxidative stress mediation, the investigators will determine if any acute impairment in endothelial function after e-hookah can be prevented by intravenous Vitamin C infusion, a potent anti-oxidant. Inflammatory and oxidant biomarkers, as well as smoking exposure biomarkers will be collected before and after the exposure sessions. The results of this proposal: (a) stand to fill in gaps in our mechanistic understanding of the comparative effect of traditional vs. e-hookah bowl on vascular and endothelial function; and (b) help inform policy decisions by the FDA about regulation of hookah products.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Endothelial Dysfunction, Inflammation, Oxidative Stress

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Charcoal-heated hookah smoking vs. electronic hookah vaping
Masking
None (Open Label)
Allocation
Randomized
Enrollment
19 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Traditional Charcoal-Heated Hookah followed by Electronic Hookah
Arm Type
Experimental
Arm Description
Participants were invited to smoke a 30-minute traditional charcoal-heated hookah-smoking session, followed by a 30-minute electronic hookah vaping session. To mitigate the impact of carryover effects, the two sessions were separated by a minimum of 7-days.
Arm Title
Electronic followed by Traditional Charcoal-Heated Hookah
Arm Type
Experimental
Arm Description
Participants were invited to vape a 30-minute electronic hookah session, followed by a 30-minute traditional charcoal-heated hookah smoking session. To mitigate the impact of carryover effects, the two sessions were separated by a minimum of 7-days.
Intervention Type
Other
Intervention Name(s)
Traditional hookah smoking
Other Intervention Name(s)
Combustible hookah smoking
Intervention Description
Charcoal-heated hookah smoking
Intervention Type
Other
Intervention Name(s)
Electronic hookah vaping
Intervention Description
Electronic hookah bowl inhalation
Primary Outcome Measure Information:
Title
Flow-Mediated Dilation (FMD)
Description
Using ultrasound, FMD of the brachial artery induced by reactive hyperemia, was used to measure endothelium-dependent vasodilator function. Baseline diameter and velocity were recorded for 45 seconds and resumed 30 seconds before cuff deflation and continuously for 2 minutes after deflation to obtain true peak vasodilatory response.
Time Frame
Pre- and post- the 30-minute smoking or vaping exposure sessions
Title
Carotid-Femoral Pulse Wave Velocity (Cf-PWV)
Description
Using applanation tonometry, cf-PWV was used to measure central arterial stiffness.
Time Frame
Pre- and post- the 30-minute smoking or vaping exposure sessions
Title
HDL Oxidant Index (HOI)
Description
Capacity was determined as the ability of HDL to inhibit LDL-induced oxidation of dihydrodichlorofluorescein into the fluorescent dichlorofluorescein. Capacity was expressed as an HDL oxidative index, determined by the ratio of dichlorofluorescein fluorescence in the presence and absence of HDL. An index of < 1.0 denotes protective antioxidant HDL, whereas an index of > 1.0 indicates pro-oxidant HDL.
Time Frame
Pre- and post- the 30-minute smoking or vaping exposure sessions
Title
Paraoxonase-1 (PON-1) Activity
Description
PON-1 activity was determined by the ability of PON-1, associated with HDL, to hydrolyze paraoxon substrate. The hydrolysis of paraoxon (diethyl-p-nitrophenyl phosphate) to p-nitrophenol by PON-1 was determined by incubating 5 mL of plasma with 1.0 mM paraoxon in 100 mM tris-HCl buffer (pH, 8.5). Unit of Measure: expressed as micromoles of p-nitrophenol formed per minute for every 1 mL plasma.
Time Frame
Pre- and post- the 30-minute smoking or vaping exposure sessions
Title
Arylesterase Activity
Description
Arylesterase activity (lipid peroxidation biomarker) was determined by the rate of hydrolysis of phenyl acetate to phenol. Briefly, 4 mL plasma was incubated with 3.5 mM phenyl acetate in 9 mM Tris-HCl buffer (pH, 8.0) containing 0.9 mM CaCl2 at RT. The kinetics of phenol formation were determined by recording the absorbance at 270 nm every 15 s for 2 min. Unit of Measure: nanomoles of product formed per minute per milliliter of plasma.
Time Frame
Pre- and post- the 30-minute smoking or vaping exposure sessions.
Title
High-sensitivity C-reactive Protein (Hs-CRP) Levels
Description
Plasma hs-CRP (inflammatory biomarker)
Time Frame
Pre- and post- the 30-minute smoking or vaping exposure sessions
Title
Tumor Necrosis Factor-α (TNFα) Concentrations
Description
Plasma TNFα (inflammatory biomarker)
Time Frame
Pre- and post- the 30-minute smoking or vaping exposure sessions
Secondary Outcome Measure Information:
Title
Flow-Mediated Dilation (FMD)
Description
Using ultrasound, FMD of the brachial artery, induced by reactive hyperemia, was used to measure endothelium-dependent vasodilator function after intravenous infusion of antioxidant ascorbic acid. Infusion of antioxidant ascorbic acid was done before the e-hookah vaping session.
Time Frame
Effect of FMD with e-hookah vaping examined after pretreatment of intravenous infusion of antioxidant ascorbic acid (administered over 60 minutes at 0.5 mL min-1)
Title
Endothelium-independent Vasodilator Function (Control Test for Endothelium-dependent Vasodilator Function)
Description
As a control test for the assessment of endothelium-dependent vasodilator function, using ultrasound the brachial artery, endothelium-independent dilatation was assessed by administering sublingual nitroglycerin. This measure was assessed 10 minutes after FMD testing. Ultrasound images were recorded continuously for a total of 10 minutes
Time Frame
Pre- and post- sublingual administration of nitroglycerin (0.15 mg), which was administrated before and after e-hookah vaping.
Title
Augmentation Index (AI)
Description
AI was used to measure central stiffness. It was calculated as the ratio of augmentation pressure (difference between the second and first systolic peaks of the aortic pressure waveform) and pulse pressure expressed as a percentage.
Time Frame
Pre- and post- the 30-minute smoking or vaping exposure sessions
Title
Interleukin 6 (IL-6) Levels
Description
Plasma IL-6 (inflammatory biomarker).
Time Frame
A change between two points is reported below (e.g., value at post-exposure session minus value at pre-exposure session).
Title
Interleukin 10 (IL-10) Levels
Description
Serum IL-10 (anti-inflammatory biomarker)
Time Frame
A change between two points is reported below (e.g., value at post-exposure session minus value at pre-exposure session).
Title
Nicotine Levels
Description
Plasma nicotine levels (smoking or vaping exposure biomarker)
Time Frame
Pre- and post- the 30-minute smoking or vaping exposure sessions
Title
Carbon Monoxide (CO) Levels
Description
Exhaled CO levels (smoking or vaping exposure biomarker)
Time Frame
Pre- and post- the 30-minute smoking or vaping exposure sessions

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
39 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 21-39 years old hookah smokers: smoked hookah >12x in last 12 months no history of illicit drugs or marijuana no evidence of cardiopulmonary disease by history/ physical no diabetes: fasting blood glucose <100 mg/dl BP<140/90mmHg resting HR<100 bpm BMI<30kg•m2 no prescription medication Exclusion Criteria: exhaled CO>10 ppm (smoking non-abstinence) positive pregnancy test psychiatric illness
Facility Information:
Facility Name
University of California, Los Angeles
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095-8361
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
34298007
Citation
Rezk-Hanna M, Gupta R, Nettle CO, Dobrin D, Cheng CW, Means A, Brecht ML, Tashkin DP, Araujo JA. Differential Effects of Electronic Hookah Vaping and Traditional Combustible Hookah Smoking on Oxidation, Inflammation, and Arterial Stiffness. Chest. 2022 Jan;161(1):208-218. doi: 10.1016/j.chest.2021.07.027. Epub 2021 Jul 21.
Results Reference
derived
PubMed Identifier
33615833
Citation
Rezk-Hanna M, Seals DR, Rossman MJ, Gupta R, Nettle CO, Means A, Dobrin D, Cheng CW, Brecht ML, Mosenifar Z, Araujo JA, Benowitz NL. Ascorbic Acid Prevents Vascular Endothelial Dysfunction Induced by Electronic Hookah (Waterpipe) Vaping. J Am Heart Assoc. 2021 Feb;10(5):e019271. doi: 10.1161/JAHA.120.019271. Epub 2021 Feb 20.
Results Reference
derived

Learn more about this trial

The Cardiovascular Effects of Electronic Hookah Vaping

We'll reach out to this number within 24 hrs